Dergiler / Acta Orthopaedica et Traumatologica Turcica / 2021 / Cilt: 55 - Sayı: 6

Extra-abdominal desmoid fibromatosis: An evaluation of clinical factors affecting local recurrence rates

Sayfa
547–551
Yayın Tarihi
2022-10-10
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The results of this study have demonstrated that tumor size ≥ 5 cm and the presence of microscopic or macroscopic positive surgical margins can increase the risk of LR, and adjuvant RT can reduce the development of LR in the management of EDT

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The aim of this study was to determine the prognostic factors for recurrence in patients with extra-abdominal desmoid tumors (EDTs) treated surgically.
📊
Temel Bulgular & Veri:Methods: This single-institution, retrospective study included patients with a histologically-proven extra-abdominal desmoid tumor between 2007 and 2018.
💡
Sonuç & Katkı:Conclusion: The results of this study have demonstrated that tumor size ≥ 5 cm and the presence of microscopic or macroscopic positive surgical margins can increase the risk of LR, and adjuvant RT can reduce the development of LR in the management of EDT
🔬Tür:Araştırma Makalesi
📍Kapsam:2007 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: The aim of this study was to determine the prognostic factors for recurrence in patients with extra-abdominal desmoid tumors (EDTs) treated surgically. Methods: This single-institution, retrospective study included patients with a histologically-proven extra-abdominal desmoid tumor between 2007 and 2018. The demographic characteristics (age, sex) of the patients, tumor characteristics (region, size, proximity to neurovascular structures, margins), treatment management (surgery and/or adjuvant radiotherapy), and clinical results were analyzed. The effects of these possible prognostic factors on overall and disease-free survival rates and the risk of local recurrence were evaluated. Results: Evaluation was made of 22 patients (16 females, 6 males) with a mean age at diagnosis of 34.7 years (range = 22-76 years). The mean follow-up was 104 months (range = 4.8-168). Tumor localization was in the upper extremity in 4 patients (18.1%), the lower extremity in 11 (50.0%), and the trunk in 7 (31.8%). The mean tumor size (maximum diameter) was 5.2 cm (range = 0.6-13 cm; median = 5.8 cm), and the mean tumor volume was 181.3 ± 531.4 ml. All the 22 patients were treated surgically along with adjuvant radiotherapy (RT) administered to 8 in addition to surgery for the primary treatment of the tumor. Following primary surgery, resection margins were R0 in 11 patients, R1 in 9 and R2 in 2. Local recurrence (LR) developed in 6 patients (27.2%) during the follow-up period. Recurrence-free survival rate (RFS) was 90.9% at one year, 74.1% at 5 years, and 61.7% at 10 years. During the follow-up, no patient died, and distant metastasis was not detected. Tumor length, resection margins, and adjuvant RT were observed to influence the risk of local recurrence (P < 0.05). Conclusion: The results of this study have demonstrated that tumor size ≥ 5 cm and the presence of microscopic or macroscopic positive surgical margins can increase the risk of LR, and adjuvant RT can reduce the development of LR in the management of EDT

🔖

Bu Makaleye Atıf Yap

Coşkun, H. S., Erdoğan, F., Çinka, H., Dabak, N. (2022). Extra-abdominal desmoid fibromatosis: An evaluation of clinical factors affecting local recurrence rates. Acta Orthopaedica et Traumatologica Turcica, Cilt: 55 - Sayı: 6, 547–551. https://ajindex.com/articles/427988

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Papagelopoulos PJ, Mavrogenis AF, Mitsiokapa EA, et al. Current trends in the management of extra-abdominal desmoid tumours. World J Surg Oncol. 2006
  2. 4 (1):1-8. 10.1186/1477-7819-4-21 2. Micke O, Seegenschmiedt MH. German Cooperative Group on Radiotherapy for Benign Diseases. Radiation therapy for aggressive fibromatosis (desmoid tumors): Results of a national patterns of care study. Int J Radiat Oncol Biol Phys. 2005
  3. 61(3):882-891. 10.1016/j.ijrobp.2004.07.705 3. Kasper B, Baumgarten C, Bonvalot S, et al. Management of sporadic desmoid- type fibromatosis: A European consensus approach based on patients’ and professionals’ expertise–a sarcoma patients EuroNet and European Organisa- tion for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative. Eur J Cancer. 2015
  4. 51(2):127-136. 10.1016/j.ejca.2014.11.005 4. De Bree E, Keus R, Melissas J, et al. Desmoid tumors: Need for an individualized approach. Expert Rev Anticancer Ther. 2009
  5. 9(4):525-535. 10.1586/era.09.9 5. Pajares B, Torres E, Jiménez B, et al. Multimodal treatment of desmoid tumours: The significance of local control. Clin Transl Oncol. 2011
  6. 13(3):189-193. 10. 1007/s12094-011-0639-4 6. Kasper B, Ströbel P, Hohenberger P. Desmoid tumors: Clinical features and treatment options for advanced disease. Oncology. 2011
  7. 16(5):682. 10.1634/ theoncologist.2010-0281 7. Ilaslan H, Schils J, Joyce M, et al. Radiofrequency ablation: Another treatment option for local control of desmoid tumors. Skelet Radiol. 2010
  8. 39(2):169-173. 10.1007/s00256-009-0807-6 8. Briand S, Barbier O, Biau D, et al. Wait-and-see policy as a first-line manage- ment for extra-abdominal desmoid tumors. JBJS. 2014
  9. 96(8):631-638. 10.2106/ JBJS.M.00988 9. Salas S, Dufresne A, Bui B, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: A wait-and-see policy according to tumor presentation. J Clin Oncol. 2011
  10. 29(26):3553-3558. 10.1200/JCO.2010.33.5489 10. Stoeckle E, Coindre JM, Longy M, et al. A critical analysis of treatment strate- gies in desmoid tumours: A review of a series of 106 cases. Eur J Surg Oncol. 2009
  11. 35(2):129-134. 10.1016/j.ejso.2008.06.1495 11. Mullen JT, DeLaney TF, Kobayashi WK, et al. Desmoid tumor: Analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol. 2012
  12. 19 (13):4028-4035. 10.1245/s10434-012-2638-2 12. Van Broekhoven DL, Verhoef C, Grunhagen DJ, et al. Prognostic value of CTNNB1 gene mutation in primary